Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/02/2000EP1047414A1 Gabapentin and its derivatives for the treatment of muscular and skeletal pain
11/02/2000EP1047413A1 Pharmazeutische zusammenstellung
11/02/2000EP1047412A1 New use of local anaesthetics against vascular headaches
11/02/2000EP1047411A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000EP1047410A1 Treatment of glc1a glaucoma with non-steroidal glucocorticoid antagonists
11/02/2000EP1047409A1 Tts containing an antioxidant
11/02/2000EP1047406A1 Autoclavable pharmaceutical compositions containing a chelating agent
11/02/2000EP1047399A1 Skin care composition
11/02/2000EP1047398A1 Topical compositions containing whey proteins
11/02/2000EP1047397A1 Topical compositions for enhancing glutathione production
11/02/2000EP1047394A1 Low-ph, acid-containing personal care compositions which exhibit reduced sting
11/02/2000EP0914331B1 Neuroactive peptides
11/02/2000EP0888316B1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors
11/02/2000EP0853619B1 Disubstituted piperidine derivatives
11/02/2000EP0853485A4 Therapeutic administration of hemoglobin in cardiac arrest
11/02/2000EP0848592B1 Antistress agents for aquatic animals
11/02/2000EP0808312B1 Indole derivatives as 5-ht receptor antagonist
11/02/2000EP0774963B1 Pharmaceutically stable oxaliplatinum preparation
11/02/2000EP0766679A4 Bioactive acetogenins and derivatives
11/02/2000EP0626844B1 Compositions of clindamycin and benzoyl peroxide for acne treatment
11/02/2000DE19919828A1 Treating male or female sexual dysfunction, especially erectile dysfunction, using propentofylline or corresponding alcohol as selective phosphodiesterase V inhibitor
11/02/2000DE19919793A1 Neue Sulfonamide New sulfonamides
11/02/2000DE19919481A1 Stabile, gegen unreine Haut und gegen Akne wirksame Wirkstoffkombinationen mit einem Gehalt an grenzflächenaktiven Glucosederivaten und Hydroxycarbonsäuren Stable, effective against blemished skin and acne drug combinations containing surface-active glucose derivatives and hydroxycarboxylic
11/02/2000DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk
11/02/2000CA2372154A1 Process of purifying phytosterols from wood or plant-derived sources and compositions resulting therefrom
11/02/2000CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000CA2371274A1 Selective npy (y5) antagonists
11/02/2000CA2371242A1 Diagnosis of human kidney diseases
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371217A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/02/2000CA2371165A1 Vitamin d analogues and their pharmaceutical use
11/02/2000CA2371114A1 Death domain containing receptors
11/02/2000CA2371064A1 Methods of delivery of cetyl myristoleate
11/02/2000CA2371055A1 Compositions and methods for improving insulin sensitivity and glucose metabolism in mammals
11/02/2000CA2371046A1 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000CA2370653A1 Pharmaceutical compositions of tetrac and methods of use thereof
11/02/2000CA2370643A1 Noscapine derivatives as adjuvant compositions and methods of use thereof
11/02/2000CA2370639A1 Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
11/02/2000CA2370607A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
11/02/2000CA2370600A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity
11/02/2000CA2370592A1 Percutaneous absorption preparations containing oxybutynin
11/02/2000CA2370590A1 Agent for suppressing the odors of sulfides formed through fermentation in the large intestine
11/02/2000CA2370581A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
11/02/2000CA2370576A1 Novel anticoagulant injectable composition
11/02/2000CA2370553A1 Cardiovascular and bone treatment using isoflavones
11/02/2000CA2370387A1 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same
11/02/2000CA2370280A1 Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
11/02/2000CA2370264A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000CA2370262A1 Thiazolidinedione derivative and its use as antidiabetic
11/02/2000CA2370258A1 Thiazolidinedione derivative and its use as antidiabetic
11/02/2000CA2370241A1 Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2370043A1 Liposome bonded with antibody and polyalkylene glycol
11/02/2000CA2369951A1 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers
11/02/2000CA2369942A1 Use of n-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients
11/02/2000CA2369910A1 Compositions and methods for treatment of hyperproliferative diseases
11/02/2000CA2369740A1 Long term administration of pharmacologically active agents
11/02/2000CA2369552A1 Agent for prophylaxis and treatment of angiostenosis
11/02/2000CA2369109A1 Thrombin inhibitors
11/02/2000CA2369092A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000CA2368205A1 N-protected amines and their use as prodrugs
11/02/2000CA2367980A1 Complete feed for fish larvae and method for preparing same
11/02/2000CA2367695A1 Heteroaryl diazacycloalkanes, their preparation and use
11/02/2000CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000CA2367681A1 Azaindole derivatives for the treatment of depression
11/01/2000CN1272139A Nucleic acids coding for proteins capable of interacting with presenilins
11/01/2000CN1272113A Lyxofuranosyl benzimidazoles as antiviral agents
11/01/2000CN1272112A Process for acylation of amino alcohols
11/01/2000CN1272111A Tricyclic vasopressin agonists
11/01/2000CN1272110A Tricyclic vasopressin agonists
11/01/2000CN1272109A Process for producing isooxazolidinedione compound
11/01/2000CN1272108A Indole derivatives as 5-HT1B and 5-HT1D agonists
11/01/2000CN1272107A Benzamidine derivatives as factor Xa inhibitors
11/01/2000CN1272105A Compound containing six-membered rings, processes for their preparation, and their use as medicaments
11/01/2000CN1272063A Prostaglandin product
11/01/2000CN1272060A Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
11/01/2000CN1272059A Carotenoid formulation
11/01/2000CN1272043A Nutritional composition for treatment of pressure ulcers
11/01/2000CN1271737A Process for preparing amylovorin of sea bacteria and its application
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition
11/01/2000CN1271733A CpG oligonucleotide with specific immunostimulation activity to human immune cell
11/01/2000CN1271731A New thiazole benzimidazole derivative
11/01/2000CN1271724A (2-substituted oxyphenyl) alkane acylamide derivative and hair nourishing agent, skin external use agent
11/01/2000CN1271592A Health-care oil for reducing cholesterol and its preparing process
11/01/2000CN1271588A Medicine for treating myopia
11/01/2000CN1271587A Medicine for treating skin ulcer
11/01/2000CN1271581A Nutritive composite bio-chemical health-care products
11/01/2000CN1271580A Medicine for treating and preventing saturnism and its preparing process
11/01/2000CN1271579A Compound vitamin for health of cardiovascular
11/01/2000CN1271578A Soluble disinfecting condom
11/01/2000CN1271577A Medicine preparation and its use and the use of high grade primary alcohol mixture
11/01/2000CN1271570A Cosmetic composition containing pigment originated from pyrolopyrrole
11/01/2000CN1058018C Androsterone derivatives and its preparing process
11/01/2000CN1058017C Intermediate for prepariny etoposide
11/01/2000CN1058016C Sulphuric acid esters of amino-sugars, its salt for medicine, preparing process and use
11/01/2000CN1058014C New heterocyclic spiro compounds, process for preparation thereof, and pharmaceutical compositions containing them
11/01/2000CN1058013C Process for preparation of novel mercaptoacetylamide derivatives
11/01/2000CN1058010C Novel quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime) pyrrolidine substituent and process for preparing thereof
11/01/2000CN1058009C 8-oxy-5,8-dihydro-6H-dibenzo [a,g] quinolizine -13-propionic acid derivant, its preparation method and medicinal use thereof
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors